Hae
Aineistot 1-1 / 1
PARP Inhibitors in Prostate Cancer – The Preclinical Rationale and Current Clinical Development
(2020-03-17)
Prostate cancer is the second most commonly diagnosed cancer type in men in the Western world. The majority of prostate cancer patients have a good prognosis, while some prostate cancers advance locally or metastasize. ...